Low Dose Naltrexone (LDN) 2021 Livestream

Low Dose Naltrexone (LDN) 2021 Livestream is organized by Low Dose Naltrexone (LDN) Research Trust.

Term of Offering:
This activity is certified for credit from June 4, 2021 to June 4, 2022. Requests for credit must be made no later than September 1, 2022.

Target Audience:
This conference has been designed for clinicians, clinical researchers, pharmacists, and well-educated patients with complex medical conditions. It is assumed that the participants will have general knowledge of human physiology and medicine, and an interest in the use of Low Dose Naltrexone

Statement of Need/Program Overview:
The LDN Research Trust partners with clinicians, clinical researchers, pharmacists, and patients to support breakthroughs in treatment for autoimmune diseases and cancer via the development of clinical trials. Now, more than ever, we must encourage life-long learning among clinicians so that they may exceed the standard of care. CME ensures the enhancement of clinicians’ performance and the pursuit of patient health.

Educational Objectives:
After completing this activity, the participant should be better able to:
• Define the mechanism of action of Low Dose Naltrexone (LDN).
• Discuss why LDN is different than regular dose naltrexone
• Describe the contradictions to use of LDN in a patient
• Describe the benefits observed in the treatment of patients with LDN
• Describe the side effects observed in the treatment of patients with LDN
• Describe commonly used adjunctive agents and lifestyle modifications in combination with LDN